Pluri and ZEO Scientifics Sign Strategic Collaboration Agreement to Expand US Manufacturing and Commercialization Platform
PLUR Pluri Inc
$1.09 -9.17%
View chart & analysis → - 1Pluri and ZEO Scientifics have signed a strategic collaboration agreement to expand their US manufacturing and commercialization platform for the regenerative medicine, aesthetics, wellness, and longevity markets.
- 2Pluri will grant ZEO Scientifics defined rights to its manufacturing technology and related know-how.
- 3ZEO Scientifics will issue common shares equivalent to 50% of the total number of ZEO issued and outstanding common shares immediately following the closing of the transaction.
So what's the key point?
Pluri and ZEO Scientifics have made plans to manufacture and sell products in the United States. ZEO Scientifics has agreed to issue half of its shares.
Source FinanceWire · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.